As of 2026-05-26, the EV/EBITDA ratio of Nanjing Vishee Medical Technology Co Ltd (688580.SS) is 46.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688580.SS's latest enterprise value is 4,752.90 mil CNY. 688580.SS's TTM EBITDA according to its financial statements is 103.10 mil CNY. Dividing these 2 quantities gives us the above 688580.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 29.6x - 39.4x | 35.6x |
| Forward P/E multiples | 14.5x - 17.7x | 16.4x |
| Fair Price | 32.87 - 50.05 | 41.11 |
| Upside | -42.6% - -12.6% | -28.2% |
| Date | EV/EBITDA |
| 2026-05-22 | 46.58 |
| 2026-05-21 | 45.95 |
| 2026-05-20 | 47.86 |
| 2026-05-19 | 49.49 |
| 2026-05-18 | 49.71 |
| 2026-05-15 | 50.67 |
| 2026-05-14 | 50.38 |
| 2026-05-13 | 51.52 |
| 2026-05-12 | 51.58 |
| 2026-05-11 | 52.83 |
| 2026-05-08 | 53.48 |
| 2026-05-07 | 52.99 |
| 2026-05-06 | 50.41 |
| 2026-04-30 | 52.60 |
| 2026-04-29 | 51.90 |
| 2026-04-28 | 51.45 |
| 2026-04-27 | 50.21 |
| 2026-04-24 | 48.86 |
| 2026-04-23 | 47.97 |
| 2026-04-22 | 49.16 |
| 2026-04-21 | 49.54 |
| 2026-04-20 | 50.15 |
| 2026-04-17 | 48.08 |
| 2026-04-16 | 47.05 |
| 2026-04-15 | 46.82 |
| 2026-04-14 | 48.42 |
| 2026-04-13 | 47.60 |
| 2026-04-10 | 43.95 |
| 2026-04-09 | 42.63 |
| 2026-04-08 | 43.86 |
| 2026-04-07 | 41.35 |
| 2026-04-03 | 41.30 |
| 2026-04-02 | 42.13 |
| 2026-04-01 | 42.47 |
| 2026-03-31 | 40.31 |
| 2026-03-30 | 41.17 |
| 2026-03-27 | 41.51 |
| 2026-03-26 | 40.33 |
| 2026-03-25 | 41.39 |
| 2026-03-24 | 41.18 |
| 2026-03-23 | 39.06 |
| 2026-03-20 | 42.46 |
| 2026-03-19 | 45.42 |
| 2026-03-18 | 47.04 |
| 2026-03-17 | 46.69 |
| 2026-03-16 | 47.99 |
| 2026-03-13 | 50.88 |
| 2026-03-12 | 51.28 |
| 2026-03-11 | 50.97 |
| 2026-03-10 | 49.14 |